Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In...
Uložené v:
| Vydané v: | The Lancet (British edition) Ročník 394; číslo 10203; s. 1041 - 1054 |
|---|---|
| Hlavní autori: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
21.09.2019
Elsevier Limited Elsevier |
| Predmet: | |
| ISSN: | 0140-6736, 1474-547X, 1474-547X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.
For this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time.
Between Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1·72 (95% CI 1·57–1·89) in patients after prostate cancer to 9·72 (5·50–17·18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1·94, 1·66–2·25, with non-Hodgkin lymphoma; 1·77, 1·50–2·09, with leukaemia; and 3·29, 2·59–4·18, with multiple myeloma), oesophageal (1·96, 1·46–2·64), lung (1·82, 1·52–2·17) kidney (1·73, 1·38–2·17) and ovarian (1·59, 1·19–2·12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy.
Survivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites.
Wellcome Trust and Royal Society. |
|---|---|
| AbstractList | The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.
For this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time.
Between Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1·72 (95% CI 1·57–1·89) in patients after prostate cancer to 9·72 (5·50–17·18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1·94, 1·66–2·25, with non-Hodgkin lymphoma; 1·77, 1·50–2·09, with leukaemia; and 3·29, 2·59–4·18, with multiple myeloma), oesophageal (1·96, 1·46–2·64), lung (1·82, 1·52–2·17) kidney (1·73, 1·38–2·17) and ovarian (1·59, 1·19–2·12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy.
Survivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites.
Wellcome Trust and Royal Society. The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.BACKGROUNDThe past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.For this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time.METHODSFor this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time.Between Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1·72 (95% CI 1·57-1·89) in patients after prostate cancer to 9·72 (5·50-17·18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1·94, 1·66-2·25, with non-Hodgkin lymphoma; 1·77, 1·50-2·09, with leukaemia; and 3·29, 2·59-4·18, with multiple myeloma), oesophageal (1·96, 1·46-2·64), lung (1·82, 1·52-2·17) kidney (1·73, 1·38-2·17) and ovarian (1·59, 1·19-2·12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy.FINDINGSBetween Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1·72 (95% CI 1·57-1·89) in patients after prostate cancer to 9·72 (5·50-17·18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1·94, 1·66-2·25, with non-Hodgkin lymphoma; 1·77, 1·50-2·09, with leukaemia; and 3·29, 2·59-4·18, with multiple myeloma), oesophageal (1·96, 1·46-2·64), lung (1·82, 1·52-2·17) kidney (1·73, 1·38-2·17) and ovarian (1·59, 1·19-2·12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy.Survivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites.INTERPRETATIONSurvivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites.Wellcome Trust and Royal Society.FUNDINGWellcome Trust and Royal Society. Summary Background The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors. Evidence is scarce on the risks of specific cardiovascular diseases in survivors of a wide range of cancers to inform prevention and management. In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps. Methods For this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to investigate effect modification, and flexible parametric survival models to estimate absolute excess risks over time. Findings Between Jan 1, 1990, and Dec 31, 2015, 126 120 individuals with a diagnosis of a cancer of interest still being followed up at least 1 year later were identified and matched to 630 144 controls. After exclusions, 108 215 cancer survivors and 523 541 controls were included in the main analyses. Venous thromboembolism risk was elevated in survivors of 18 of 20 site-specific cancers compared with that of controls; adjusted hazard ratios (HRs) ranged from 1·72 (95% CI 1·57–1·89) in patients after prostate cancer to 9·72 (5·50–17·18) after pancreatic cancer. HRs decreased over time, but remained elevated more than 5 years after diagnosis. We observed increased risks of heart failure or cardiomyopathy in patients after ten of 20 cancers, including haematological (adjusted HR 1·94, 1·66–2·25, with non-Hodgkin lymphoma; 1·77, 1·50–2·09, with leukaemia; and 3·29, 2·59–4·18, with multiple myeloma), oesophageal (1·96, 1·46–2·64), lung (1·82, 1·52–2·17) kidney (1·73, 1·38–2·17) and ovarian (1·59, 1·19–2·12). Elevated risks of arrhythmia, pericarditis, coronary artery disease, stroke, and valvular heart disease were also observed for multiple cancers, including haematological malignancies. HRs for heart failure or cardiomyopathy and venous thromboembolism were greater in patients without previous cardiovascular disease and in younger patients. However, absolute excess risks were generally greater with increasing age. Increased risks of these outcomes seemed most pronounced in patients who had received chemotherapy. Interpretation Survivors of most site-specific cancers had increased medium-term to long-term risk for one or more cardiovascular diseases compared with that for the general population, with substantial variations between cancer sites. Funding Wellcome Trust and Royal Society. |
| Author | Gadd, Sarah Matthews, Anthony Mansfield, Kathryn E Smeeth, Liam Bhaskaran, Krishnan Stanway, Susannah Strongman, Helen Lyon, Alexander R dos-Santos-Silva, Isabel |
| AuthorAffiliation | d Breast Unit, Royal Marsden Hospital, London, UK a Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK f Health Data Research UK, London, UK c Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden b School of Geography, University of Leeds, Leeds, UK e Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK |
| AuthorAffiliation_xml | – name: d Breast Unit, Royal Marsden Hospital, London, UK – name: b School of Geography, University of Leeds, Leeds, UK – name: f Health Data Research UK, London, UK – name: a Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – name: c Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden – name: e Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK |
| Author_xml | – sequence: 1 givenname: Helen surname: Strongman fullname: Strongman, Helen organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 2 givenname: Sarah surname: Gadd fullname: Gadd, Sarah organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 3 givenname: Anthony surname: Matthews fullname: Matthews, Anthony organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 4 givenname: Kathryn E surname: Mansfield fullname: Mansfield, Kathryn E organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 5 givenname: Susannah surname: Stanway fullname: Stanway, Susannah organization: Breast Unit, Royal Marsden Hospital, London, UK – sequence: 6 givenname: Alexander R surname: Lyon fullname: Lyon, Alexander R organization: Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, UK – sequence: 7 givenname: Isabel surname: dos-Santos-Silva fullname: dos-Santos-Silva, Isabel organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 8 givenname: Liam surname: Smeeth fullname: Smeeth, Liam organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK – sequence: 9 givenname: Krishnan surname: Bhaskaran fullname: Bhaskaran, Krishnan email: krishnan.bhaskaran@lshtm.ac.uk organization: Department of Non-Communicable Diseases Epidemiology, London School of Hygiene & Tropical Medicine, London, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31443926$$D View this record in MEDLINE/PubMed http://kipublications.ki.se/Default.aspx?queryparsed=id:141910350$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNqNkt1u0zAYhiM0xLrCJYAscTIOAnbi2A0TIDTxJ4Y4gEmcWa79pfXq2MV2inpx3BvuDxXryTiKFT_Payffe1acOO-gKB4T_Jxgwl58w4TikvGanZP2WU0Yp2VzrxgRullQ_uOkGB2Q0-IsxhuMMWW4eVCc1oTSuq3YqPj9BbQZeiSdRta7WZkg9CiYuIjIdyguQZnOKKRk0MavZFSDlQFpE0FGiMg4FIewMisftkKFkdSDTVlwCkJ8iSRa-mWWkvGunGZJI-XnPiQU06DXaIjGzVCfHbO0gKxxi4xcf0ZgQaXgXT59DtKmOQqgfNARaZnkJik-LO530kZ4tH-Oi-v3775ffiyvvn74dPn2qlSsqVNJW0XqtuWcTEEr3MhOcw6MMS4JUWoy0V2tJde6w1g3mILE01ZipgArjnFVj4tylxt_wXKYimUwvQxr4aUR-1eLvAJBOaecZf71js87fT4SXArS3tJu7zgzFzO_EmzScJpnMy7O9wHB_xwgJtGbqMBa6cAPUVRVy0jVNlWb0adH6I0fgsu_Y0PVfEIxJ5l68u-NDlf524QMNDtABR9jgO6AECw2jRPbxolNnQRpxbZxosnexZGnTNoOO3-YsXfab3Y25OmtDAQRlYHcHG3ysJPQ3tyZ8OooQeUKGSXtAtb_4f8BKKQIvQ |
| CitedBy_id | crossref_primary_10_1007_s10072_025_08502_2 crossref_primary_10_1186_s12916_023_03153_6 crossref_primary_10_7554_eLife_84919 crossref_primary_10_3389_fcvm_2022_892335 crossref_primary_10_3389_fcvm_2021_812702 crossref_primary_10_4103_aja_aja_58_21 crossref_primary_10_3390_biom14020199 crossref_primary_10_1007_s11912_020_00930_x crossref_primary_10_1159_000547896 crossref_primary_10_3389_fonc_2022_919522 crossref_primary_10_1016_j_jaccao_2023_07_010 crossref_primary_10_1002_cam4_6580 crossref_primary_10_1038_s41598_021_00666_z crossref_primary_10_1186_s13063_021_05843_z crossref_primary_10_1016_j_cdtm_2019_12_007 crossref_primary_10_1007_s00520_025_09869_w crossref_primary_10_1155_2022_1451881 crossref_primary_10_1186_s12872_023_03613_0 crossref_primary_10_1016_j_cllc_2024_02_005 crossref_primary_10_1016_j_jaccao_2022_01_102 crossref_primary_10_3390_antiox9121182 crossref_primary_10_1038_s41409_021_01414_7 crossref_primary_10_3390_cells10082069 crossref_primary_10_1002_ajh_26230 crossref_primary_10_3389_fcvm_2024_1382166 crossref_primary_10_1016_S0140_6736_20_30238_5 crossref_primary_10_1186_s12872_025_04976_2 crossref_primary_10_1016_j_apgeog_2020_102360 crossref_primary_10_1177_11786469221096643 crossref_primary_10_1055_a_2495_1350 crossref_primary_10_1186_s40959_024_00299_x crossref_primary_10_1186_s41231_024_00189_5 crossref_primary_10_1186_s12885_022_09944_z crossref_primary_10_1016_S0140_6736_22_02582_X crossref_primary_10_1016_j_jaccao_2024_05_015 crossref_primary_10_1111_ijcp_14758 crossref_primary_10_1093_ehjqcco_qcac045 crossref_primary_10_1016_j_jaccao_2025_03_008 crossref_primary_10_1093_jncics_pkab016 crossref_primary_10_1177_20406207221086755 crossref_primary_10_1016_j_thromres_2025_109455 crossref_primary_10_1161_JAHA_119_018393 crossref_primary_10_1136_heartjnl_2022_321888 crossref_primary_10_3390_medsci9020041 crossref_primary_10_1186_s11658_023_00451_y crossref_primary_10_1016_j_amjcard_2020_09_030 crossref_primary_10_3389_fcvm_2022_1024846 crossref_primary_10_3389_fcvm_2022_926218 crossref_primary_10_1016_j_ajpc_2020_100119 crossref_primary_10_1016_j_pharmthera_2024_108670 crossref_primary_10_1186_s12885_022_09519_y crossref_primary_10_3390_jcm9051268 crossref_primary_10_1016_j_jaccao_2022_02_003 crossref_primary_10_1093_eurheartj_ehab674 crossref_primary_10_1093_pnasnexus_pgae513 crossref_primary_10_1002_cam4_4862 crossref_primary_10_1038_s41598_022_09361_z crossref_primary_10_3389_fcvm_2021_721107 crossref_primary_10_1016_j_ijcard_2021_07_054 crossref_primary_10_1093_ehjimp_qyaf075 crossref_primary_10_3390_antiox9020140 crossref_primary_10_1007_s40119_022_00285_3 crossref_primary_10_1016_j_clon_2022_08_028 crossref_primary_10_1016_j_cllc_2022_06_005 crossref_primary_10_1093_ehjopen_oeaf039 crossref_primary_10_1186_s40959_021_00105_y crossref_primary_10_3389_fcvm_2022_925816 crossref_primary_10_1016_j_yjmcc_2022_06_008 crossref_primary_10_3389_fcvm_2022_858334 crossref_primary_10_1161_JAHA_120_019373 crossref_primary_10_26442_20751753_2025_8_203064 crossref_primary_10_1016_j_ajpc_2024_100926 crossref_primary_10_1016_j_ijcard_2022_09_075 crossref_primary_10_1016_j_semcancer_2023_11_004 crossref_primary_10_1093_eurheartj_ehaf100 crossref_primary_10_1038_s41598_021_82026_5 crossref_primary_10_1158_1055_9965_EPI_23_1635 crossref_primary_10_1002_cncr_32900 crossref_primary_10_3390_ijerph17082841 crossref_primary_10_1093_eurjpc_zwad243 crossref_primary_10_1016_j_biomaterials_2020_120631 crossref_primary_10_1016_j_mayocp_2024_08_014 crossref_primary_10_1093_ajh_hpae099 crossref_primary_10_1097_SPC_0000000000000544 crossref_primary_10_1007_s10741_021_10151_4 crossref_primary_10_1097_MD_0000000000043378 crossref_primary_10_1136_heartjnl_2024_325309 crossref_primary_10_1371_journal_pdig_0000640 crossref_primary_10_1016_j_diabet_2021_101289 crossref_primary_10_3390_cancers14020434 crossref_primary_10_1007_s11886_020_01380_4 crossref_primary_10_1016_j_jaccao_2025_07_004 crossref_primary_10_1371_journal_pone_0300154 crossref_primary_10_1002_hon_2943 crossref_primary_10_3390_jcm9082664 crossref_primary_10_1016_j_ijbiomac_2020_10_266 crossref_primary_10_1007_s10549_020_05758_4 crossref_primary_10_1007_s11764_023_01363_8 crossref_primary_10_3390_cancers13235903 crossref_primary_10_1007_s10120_024_01540_3 crossref_primary_10_1097_CM9_0000000000003419 crossref_primary_10_1002_cam4_6305 crossref_primary_10_1007_s12032_025_02806_1 crossref_primary_10_1016_j_jaccao_2025_06_003 crossref_primary_10_1161_CIR_0000000000001158 crossref_primary_10_1186_s13073_023_01266_4 crossref_primary_10_3390_cancers17060983 crossref_primary_10_1186_s40959_024_00285_3 crossref_primary_10_1080_08977194_2021_1932870 crossref_primary_10_1093_cvr_cvad104 crossref_primary_10_3390_ijms26010334 crossref_primary_10_1111_eci_14161 crossref_primary_10_1016_j_ygyno_2022_05_004 crossref_primary_10_1038_s41568_025_00861_4 crossref_primary_10_2478_sjph_2021_0028 crossref_primary_10_1007_s11912_022_01309_w crossref_primary_10_1126_scitranslmed_abj9625 crossref_primary_10_1002_cam4_3844 crossref_primary_10_2217_fca_2019_0066 crossref_primary_10_1016_j_currproblcancer_2023_101015 crossref_primary_10_1007_s11897_021_00535_w crossref_primary_10_1161_JAHA_124_037965 crossref_primary_10_1016_j_jaccao_2019_11_007 crossref_primary_10_1002_cncr_34224 crossref_primary_10_1016_j_jtho_2023_09_004 crossref_primary_10_1016_j_cardfail_2025_02_014 crossref_primary_10_1038_s41586_020_2521_4 crossref_primary_10_1089_scd_2020_0044 crossref_primary_10_1136_heartjnl_2022_321324 crossref_primary_10_1097_MD_0000000000034097 crossref_primary_10_1016_j_lanwpc_2025_101519 crossref_primary_10_7554_eLife_95901_3 crossref_primary_10_1002_ejhf_2818 crossref_primary_10_1007_s00103_023_03691_7 crossref_primary_10_1093_jnci_djae107 crossref_primary_10_3389_fonc_2023_1124447 crossref_primary_10_3390_jcm14155573 crossref_primary_10_3389_fcvm_2022_901431 crossref_primary_10_1002_jmri_28667 crossref_primary_10_1016_j_jdmv_2021_08_001 crossref_primary_10_1093_eurjpc_zwaf356 crossref_primary_10_2478_jtim_2023_0112 crossref_primary_10_1093_ije_dyab082 crossref_primary_10_1007_s10115_022_01813_2 crossref_primary_10_1186_s12916_024_03484_y crossref_primary_10_1186_s12885_022_10314_y crossref_primary_10_1016_j_clon_2021_03_012 crossref_primary_10_1016_j_rec_2020_11_020 crossref_primary_10_1136_bmj_2025_084062 crossref_primary_10_1016_j_jacadv_2025_101884 crossref_primary_10_3390_cancers14194783 crossref_primary_10_1016_j_chest_2020_11_010 crossref_primary_10_1111_1471_0528_17410 crossref_primary_10_1182_bloodadvances_2020004118 crossref_primary_10_1007_s11936_020_00883_1 crossref_primary_10_1016_j_hipert_2021_02_006 crossref_primary_10_1093_jnci_djaa096 crossref_primary_10_1093_jncics_pkab001 crossref_primary_10_1001_jamanetworkopen_2023_23752 crossref_primary_10_1016_j_echo_2022_01_018 crossref_primary_10_1016_j_ijchy_2021_100085 crossref_primary_10_1161_JAHA_123_033295 crossref_primary_10_1161_CIRCRESAHA_125_325489 crossref_primary_10_1253_circj_CJ_25_0002 crossref_primary_10_1002_cam4_5122 crossref_primary_10_1093_eurjpc_zwad046 crossref_primary_10_1161_JAHA_121_022806 crossref_primary_10_1016_j_ahj_2025_04_026 crossref_primary_10_1016_j_jaccao_2024_09_012 crossref_primary_10_1016_j_ctrv_2025_102992 crossref_primary_10_1016_j_canep_2025_102848 crossref_primary_10_1016_j_jtcvs_2020_10_030 crossref_primary_10_1098_rsob_220124 crossref_primary_10_1016_j_blre_2024_101220 crossref_primary_10_1177_00033197241255168 crossref_primary_10_1080_13697137_2023_2286382 crossref_primary_10_1161_CIRCRESAHA_123_322984 crossref_primary_10_1186_s12889_022_12962_y crossref_primary_10_1097_HCO_0000000000000878 crossref_primary_10_3389_fonc_2025_1557175 crossref_primary_10_1016_j_jgo_2020_09_010 crossref_primary_10_1159_000534182 crossref_primary_10_1038_s41371_020_00400_8 crossref_primary_10_1016_j_ijcard_2020_07_033 crossref_primary_10_1002_pds_5243 crossref_primary_10_2196_24137 crossref_primary_10_3390_cancers12040917 crossref_primary_10_1002_ehf2_13923 crossref_primary_10_3390_jpm11060487 crossref_primary_10_1016_j_jnma_2023_07_004 crossref_primary_10_1136_bmjonc_2023_000090 crossref_primary_10_5694_mja2_50995 crossref_primary_10_1186_s13102_023_00634_2 crossref_primary_10_1186_s40959_025_00373_y crossref_primary_10_1016_j_cjca_2024_03_012 crossref_primary_10_1016_j_jaccao_2025_05_003 crossref_primary_10_1016_S0140_6736_20_30222_1 crossref_primary_10_1016_j_lana_2024_100712 crossref_primary_10_1016_j_envpol_2022_119070 crossref_primary_10_1007_s11764_023_01372_7 crossref_primary_10_1016_j_heliyon_2024_e34176 crossref_primary_10_1016_S2352_3026_22_00082_5 crossref_primary_10_1016_j_ygyno_2020_11_023 crossref_primary_10_1007_s12094_020_02477_6 crossref_primary_10_1097_CCO_0000000000000735 crossref_primary_10_1111_dme_14538 crossref_primary_10_1111_echo_70030 crossref_primary_10_57264_cer_2024_0130 crossref_primary_10_1007_s11764_021_01122_7 crossref_primary_10_1093_ije_dyad170 crossref_primary_10_1007_s11864_020_00777_1 crossref_primary_10_1016_j_socscimed_2025_118078 crossref_primary_10_3390_biomedicines10112681 crossref_primary_10_1002_clc_70135 crossref_primary_10_1016_j_cardfail_2024_08_045 crossref_primary_10_1016_j_jaccao_2024_07_006 crossref_primary_10_1093_jjco_hyab001 crossref_primary_10_1097_JCN_0000000000001040 crossref_primary_10_1002_cam4_70329 crossref_primary_10_1016_j_amjcard_2020_11_005 crossref_primary_10_3390_life12010045 crossref_primary_10_12998_wjcc_v10_i20_6825 crossref_primary_10_1038_s41416_023_02506_5 crossref_primary_10_1016_j_hlc_2023_11_006 crossref_primary_10_1016_j_jaccao_2023_10_008 crossref_primary_10_1136_heartjnl_2025_326670 crossref_primary_10_3389_fonc_2022_823115 crossref_primary_10_1093_eurjpc_zwae181 crossref_primary_10_1007_s12471_020_01517_8 crossref_primary_10_1002_cam4_3934 crossref_primary_10_1186_s12885_023_11329_9 crossref_primary_10_1161_CIRCIMAGING_121_012459 crossref_primary_10_1186_s44201_022_00017_2 crossref_primary_10_1186_s13244_025_01907_9 crossref_primary_10_1093_cvr_cvae098 crossref_primary_10_1182_bloodadvances_2024013620 crossref_primary_10_1093_fampra_cmaa009 crossref_primary_10_1002_btm2_10570 crossref_primary_10_1016_j_cpcardiol_2023_101693 crossref_primary_10_1007_s12012_024_09845_6 crossref_primary_10_1007_s11886_024_02099_2 crossref_primary_10_1371_journal_pone_0282859 crossref_primary_10_3389_fcvm_2022_857194 crossref_primary_10_3390_cancers14061577 crossref_primary_10_1016_j_hlc_2023_11_017 crossref_primary_10_1016_j_jacc_2022_04_042 crossref_primary_10_1097_CEJ_0000000000000921 crossref_primary_10_31083_RCM24981 crossref_primary_10_1055_a_1195_6425 crossref_primary_10_3389_fimmu_2024_1439231 crossref_primary_10_3389_fonc_2022_1025398 crossref_primary_10_1093_ije_dyae049 crossref_primary_10_1161_JAHA_119_013755 crossref_primary_10_1016_j_semerg_2025_102460 crossref_primary_10_1161_CIRCULATIONAHA_121_054698 crossref_primary_10_1002_ajh_25764 crossref_primary_10_1007_s42399_025_02051_7 crossref_primary_10_1007_s11912_020_00923_w crossref_primary_10_1161_JAHA_124_036411 crossref_primary_10_1016_j_esmoop_2025_105539 crossref_primary_10_1016_j_ygyno_2022_03_025 crossref_primary_10_1007_s40520_024_02851_2 crossref_primary_10_1097_MJT_0000000000001970 crossref_primary_10_1016_j_jacadv_2025_102129 crossref_primary_10_1371_journal_pone_0247919 crossref_primary_10_3390_cancers14194572 crossref_primary_10_1093_ageing_afad068 crossref_primary_10_1002_cam4_7180 crossref_primary_10_1080_14779072_2025_2463332 crossref_primary_10_3390_cancers13246203 crossref_primary_10_1186_s40959_020_00074_8 crossref_primary_10_1200_JCO_24_00342 crossref_primary_10_3390_cancers17071117 crossref_primary_10_1186_s12885_021_08716_5 crossref_primary_10_3390_ijerph18157996 crossref_primary_10_1016_j_tcm_2024_04_004 crossref_primary_10_1093_eurheartj_ehae052 crossref_primary_10_1136_spcare_2023_004440 crossref_primary_10_1016_j_amjcard_2023_11_039 crossref_primary_10_1093_ehjqcco_qcac016 crossref_primary_10_1186_s40959_025_00355_0 crossref_primary_10_1136_heartjnl_2025_326282 crossref_primary_10_1016_j_hfc_2022_02_010 crossref_primary_10_1016_S0140_6736_19_31886_0 crossref_primary_10_1016_S0140_6736_20_30232_4 crossref_primary_10_1212_WNL_0000000000011264 crossref_primary_10_1038_s41416_023_02421_9 crossref_primary_10_1038_s41598_023_43839_8 crossref_primary_10_1093_jncics_pkab067 crossref_primary_10_1093_jnci_djaf122 crossref_primary_10_15829_1728_8800_2024_4051 crossref_primary_10_1053_j_seminoncol_2022_06_004 crossref_primary_10_3390_cancers13030427 crossref_primary_10_1111_jhn_12857 crossref_primary_10_1002_hed_27604 crossref_primary_10_1093_cvr_cvaa222 crossref_primary_10_1016_S0140_6736_22_02405_9 crossref_primary_10_1001_jamanetworkopen_2022_54669 crossref_primary_10_1186_s44348_024_00014_5 crossref_primary_10_1016_j_physio_2025_101788 crossref_primary_10_1093_ije_dyad097 crossref_primary_10_3390_cancers15153992 crossref_primary_10_4081_btvb_2025_167 crossref_primary_10_1016_j_heliyon_2024_e36954 crossref_primary_10_1016_j_ctrv_2025_102903 crossref_primary_10_1161_JAHA_124_038180 crossref_primary_10_1136_bmjopen_2022_066029 crossref_primary_10_1016_j_hfc_2022_02_001 crossref_primary_10_1016_j_numecd_2024_03_018 crossref_primary_10_3390_ph15080919 crossref_primary_10_1016_j_amjcard_2023_08_121 crossref_primary_10_1186_s12967_023_04498_5 crossref_primary_10_1097_FJC_0000000000001342 crossref_primary_10_3390_nu13072319 crossref_primary_10_1002_cam4_70038 crossref_primary_10_1001_jama_2019_17415 crossref_primary_10_3389_fimmu_2025_1637144 crossref_primary_10_3390_cancers12113316 crossref_primary_10_31083_RCM24940 crossref_primary_10_3390_cancers17152506 crossref_primary_10_1016_S2352_3026_20_30031_4 crossref_primary_10_1093_tbm_ibae058 crossref_primary_10_1038_s41416_022_01935_y crossref_primary_10_1016_j_jand_2022_05_005 crossref_primary_10_3389_fcvm_2021_763557 crossref_primary_10_1097_JCN_0000000000000848 crossref_primary_10_1093_oncolo_oyaf002 crossref_primary_10_1093_eurjpc_zwac229 crossref_primary_10_1038_s41598_024_78787_4 crossref_primary_10_1007_s00520_023_07925_x crossref_primary_10_1177_23993693211001374 crossref_primary_10_1016_j_cpcardiol_2023_102176 crossref_primary_10_1111_jhn_12877 crossref_primary_10_7554_eLife_95901 crossref_primary_10_1002_jha2_638 crossref_primary_10_3390_cancers15215222 crossref_primary_10_1038_s41598_025_97821_7 |
| Cites_doi | 10.1200/JCO.2015.64.0409 10.1093/jnci/dju110 10.1161/CIRCULATIONAHA.115.017719 10.1161/CIRCRESAHA.115.303633 10.1002/sim.3944 10.1016/j.jacc.2017.09.1096 10.1007/s10654-018-0442-4 10.1186/s12885-018-4947-8 10.1161/CIRCULATIONAHA.115.020406 10.1007/s12094-018-02015-5 10.1093/eurheartj/ehw211 10.1016/j.puhe.2017.10.005 10.1093/eurheartj/ehy453 10.1161/CIR.0000000000000556 10.1016/j.jacc.2017.09.1095 10.1056/NEJMoa1209825 10.1038/sj.bjc.6605883 10.1136/bmj.f2350 10.1111/j.1365-2125.2009.03537.x 10.1200/JCO.2017.76.3920 10.1007/s10549-014-3021-8 10.1161/CIRCULATIONAHA.116.022514 10.1016/j.ijrobp.2015.11.040 10.1093/annonc/mdr160 10.1093/ije/dyv098 10.1136/oem.2006.026690 10.1093/jnci/djs317 10.1016/j.canep.2018.08.009 10.1002/ejhf.1292 10.1182/blood-2015-01-625582 10.1002/cncr.30364 10.1002/cam4.1754 10.1186/1471-2407-10-337 10.3399/bjgp15X687409 10.1093/jnci/djy218 10.1177/1536867X0900900206 |
| ContentType | Journal Article |
| Copyright | 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. 2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 |
| Copyright_xml | – notice: 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. – notice: 2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. – notice: 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2019 |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 5PM ADTPV AOWAS D8T ZZAVC |
| DOI | 10.1016/S0140-6736(19)31674-5 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database (ProQuest) Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional Biological Sciences Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Psychology Database (ProQuest) Research Library Science Database (ProQuest) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest One Psychology MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-547X |
| EndPage | 1054 |
| ExternalDocumentID | oai_swepub_ki_se_477476 PMC6857444 31443926 10_1016_S0140_6736_19_31674_5 S0140673619316745 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom United Kingdom--UK |
| GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK |
| GrantInformation | Wellcome Trust and Royal Society. |
| GrantInformation_xml | – fundername: Wellcome Trust |
| GroupedDBID | --- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHMBA AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD 04C 6I. 88A AACTN AAFTH ABLVK ABYKQ AFKWA AJOXV AMFUW M0L M41 RIG SDF XFK ZA5 .GJ 3EH 3O- 41~ 8WZ 9DU A6W AAEJM AAKAS AAQXK AAYXX ABDBF ABWVN ACRPL ACUHS ADMUD ADNMO ADXHL ADZCM AFFHD AFFNX AGQPQ AHHHB AHQJS AIGII AJJEV AKVCP ARTTT ASPBG AVWKF AZFZN CITATION D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H MVM OVD Q~Q R2- SV3 TEORI TH9 UHU UQL WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 AFCTW ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM ADTPV AOWAS D8T ZZAVC |
| ID | FETCH-LOGICAL-c653t-49c1399771bedc05afd77e6667a11cc88df3da7ddf00d504ea0b9a06ce0c70023 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 385 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000487038700031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Tue Nov 25 03:36:19 EST 2025 Tue Nov 04 02:01:21 EST 2025 Sun Sep 28 12:18:46 EDT 2025 Tue Oct 07 07:34:20 EDT 2025 Wed Feb 19 02:05:28 EST 2025 Tue Nov 18 22:41:11 EST 2025 Sat Nov 29 07:25:12 EST 2025 Fri Feb 23 02:49:11 EST 2024 Tue Oct 14 19:33:03 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10203 |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c653t-49c1399771bedc05afd77e6667a11cc88df3da7ddf00d504ea0b9a06ce0c70023 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:141910350 |
| PMID | 31443926 |
| PQID | 2293784071 |
| PQPubID | 40246 |
| PageCount | 14 |
| ParticipantIDs | swepub_primary_oai_swepub_ki_se_477476 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6857444 proquest_miscellaneous_2296129529 proquest_journals_2293784071 pubmed_primary_31443926 crossref_primary_10_1016_S0140_6736_19_31674_5 crossref_citationtrail_10_1016_S0140_6736_19_31674_5 elsevier_sciencedirect_doi_10_1016_S0140_6736_19_31674_5 elsevier_clinicalkey_doi_10_1016_S0140_6736_19_31674_5 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-09-21 |
| PublicationDateYYYYMMDD | 2019-09-21 |
| PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-21 day: 21 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2019 |
| Publisher | Elsevier Ltd Elsevier Limited Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited – name: Elsevier |
| References | (bib25) 2019 Pareek, Cevallos, Moliner (bib40) 2018; 20 Arhi, Bottle, Burns (bib33) 2018; 57 Boekel, Schaapveld, Gietema (bib24) 2016; 94 Austin, Lee, Fine (bib17) 2016; 133 Jordan, Thwin, Lash (bib22) 2014; 146 Pearce, Checkoway, Kriebel (bib18) 2007; 64 Herrett, Thomas, Schoonen, Smeeth, Hall (bib31) 2010; 69 Schoormans, Vissers, van Herk-Sukel (bib10) 2018; 7 Riihimaki, Thomsen, Brandt, Sundquist, Hemminki (bib26) 2012; 23 Tweed, Allardice, McLoone, Morrison (bib27) 2018; 154 Ameijide, Clèries, Carulla (bib23) 2019 Virani, Dent, Brezden-Masley (bib7) 2016; 32 Textor, van der Zander, Gilthorpe, Liśkiewicz, Ellison (bib15) 2017; 45 Padmanabhan, Carty, Cameron, Ghosh, Williams, Strongman (bib13) 2019; 34 Bowles, Wellman, Feigelson (bib36) 2012; 104 Chidwick, Strongman, Matthews (bib43) 2018; 18 Hippisley-Cox, Coupland, Brindle (bib39) 2017; 357 Power, Izawa (bib20) 2016; 2 Zamorano, Lancellotti, Rodriguez Munoz (bib2) 2016; 37 Mehta, Watson, Barac (bib8) 2018; 137 Henson, Reulen, Winter (bib9) 2016; 134 Walter, Usher-Smith, Yadlapalli, Watson (bib42) 2015; 65 Cronin-Fenton, Søndergaard, Pedersen (bib29) 2010; 103 Armenian, Xu, Ky (bib19) 2016; 34 Armenian, Armstrong, Aune (bib6) 2018; 36 Smith, Cornelius, Plummer (bib35) 2010; 10 Lambert, Royston (bib16) 2009; 9 Darby, Ewertz, McGale (bib37) 2013; 368 Brand, Hedayati, Bhoo-Pathy (bib28) 2017; 123 Chang, Moudgil, Scarabelli, Okwuosa, Yeh (bib4) 2017; 70 Walker, West, Card, Crooks, Kirwan, Grainge (bib30) 2016; 127 Abdel-Qadir, Thavendiranathan, Austin (bib21) 2019 Lancellotti, Suter, Lo (bib41) 2019; 40 (bib1) 2019 Herrett, Gallagher, Bhaskaran (bib12) 2015; 44 Herrett, Shah, Boggon (bib32) 2013; 346 Chang, Okwuosa, Scarabelli, Moudgil, Yeh (bib5) 2017; 70 Rugbjerg, Mellemkjaer, Boice, Køber, Ewertz, Olsen (bib11) 2014; 106 (bib14) 2018 Koene, Prizment, Blaes, Konety (bib3) 2016; 133 Lenneman, Sawyer (bib38) 2016; 118 White, Carlin (bib34) 2010; 29 Lenneman (10.1016/S0140-6736(19)31674-5_bib38) 2016; 118 Riihimaki (10.1016/S0140-6736(19)31674-5_bib26) 2012; 23 Zamorano (10.1016/S0140-6736(19)31674-5_bib2) 2016; 37 Walter (10.1016/S0140-6736(19)31674-5_bib42) 2015; 65 Tweed (10.1016/S0140-6736(19)31674-5_bib27) 2018; 154 Hippisley-Cox (10.1016/S0140-6736(19)31674-5_bib39) 2017; 357 Textor (10.1016/S0140-6736(19)31674-5_bib15) 2017; 45 Darby (10.1016/S0140-6736(19)31674-5_bib37) 2013; 368 Koene (10.1016/S0140-6736(19)31674-5_bib3) 2016; 133 Herrett (10.1016/S0140-6736(19)31674-5_bib12) 2015; 44 Henson (10.1016/S0140-6736(19)31674-5_bib9) 2016; 134 Walker (10.1016/S0140-6736(19)31674-5_bib30) 2016; 127 Chang (10.1016/S0140-6736(19)31674-5_bib4) 2017; 70 White (10.1016/S0140-6736(19)31674-5_bib34) 2010; 29 Brand (10.1016/S0140-6736(19)31674-5_bib28) 2017; 123 Bowles (10.1016/S0140-6736(19)31674-5_bib36) 2012; 104 Lancellotti (10.1016/S0140-6736(19)31674-5_bib41) 2019; 40 Schoormans (10.1016/S0140-6736(19)31674-5_bib10) 2018; 7 Pearce (10.1016/S0140-6736(19)31674-5_bib18) 2007; 64 Rugbjerg (10.1016/S0140-6736(19)31674-5_bib11) 2014; 106 Austin (10.1016/S0140-6736(19)31674-5_bib17) 2016; 133 Armenian (10.1016/S0140-6736(19)31674-5_bib19) 2016; 34 Cronin-Fenton (10.1016/S0140-6736(19)31674-5_bib29) 2010; 103 Smith (10.1016/S0140-6736(19)31674-5_bib35) 2010; 10 Pareek (10.1016/S0140-6736(19)31674-5_bib40) 2018; 20 Chidwick (10.1016/S0140-6736(19)31674-5_bib43) 2018; 18 Lambert (10.1016/S0140-6736(19)31674-5_bib16) 2009; 9 Herrett (10.1016/S0140-6736(19)31674-5_bib31) 2010; 69 Abdel-Qadir (10.1016/S0140-6736(19)31674-5_bib21) 2019 Padmanabhan (10.1016/S0140-6736(19)31674-5_bib13) 2019; 34 Virani (10.1016/S0140-6736(19)31674-5_bib7) 2016; 32 Arhi (10.1016/S0140-6736(19)31674-5_bib33) 2018; 57 Boekel (10.1016/S0140-6736(19)31674-5_bib24) 2016; 94 Mehta (10.1016/S0140-6736(19)31674-5_bib8) 2018; 137 Herrett (10.1016/S0140-6736(19)31674-5_bib32) 2013; 346 Chang (10.1016/S0140-6736(19)31674-5_bib5) 2017; 70 Power (10.1016/S0140-6736(19)31674-5_bib20) 2016; 2 Jordan (10.1016/S0140-6736(19)31674-5_bib22) 2014; 146 Armenian (10.1016/S0140-6736(19)31674-5_bib6) 2018; 36 Ameijide (10.1016/S0140-6736(19)31674-5_bib23) 2019 32563368 - Lancet. 2020 Jun 20;395(10241):1903-1904 32563370 - Lancet. 2020 Jun 20;395(10241):1904 31443925 - Lancet. 2019 Sep 21;394(10203):986-988 |
| References_xml | – year: 2019 ident: bib23 article-title: Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona publication-title: Clin Transl Oncol – volume: 357 year: 2017 ident: bib39 article-title: Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study publication-title: BMJ – volume: 40 start-page: 1756 year: 2019 end-page: 1763 ident: bib41 article-title: Cardio-oncology services: rationale, organization, and implementation publication-title: Eur Heart J – volume: 69 start-page: 4 year: 2010 end-page: 14 ident: bib31 article-title: Validation and validity of diagnoses in the General Practice Research Database: a systematic review publication-title: Br J Clin Pharmacol – volume: 133 start-page: 1104 year: 2016 end-page: 1114 ident: bib3 article-title: Shared risk factors in cardiovascular disease and cancer publication-title: Circulation – volume: 23 start-page: 604 year: 2012 end-page: 610 ident: bib26 article-title: Death causes in breast cancer patients publication-title: Ann Oncol – volume: 368 start-page: 987 year: 2013 end-page: 998 ident: bib37 article-title: Risk of ischemic heart disease in women after radiotherapy for breast cancer publication-title: N Engl J Med – volume: 127 start-page: 849 year: 2016 end-page: 857 ident: bib30 article-title: When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data publication-title: Blood – volume: 65 start-page: e761 year: 2015 end-page: e768 ident: bib42 article-title: Caring for people living with, and beyond, cancer: an online survey of GPs in England publication-title: Br J Gen Pract – volume: 2 start-page: 27 year: 2016 end-page: 36 ident: bib20 article-title: Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE) publication-title: Bl Cancer – volume: 57 start-page: 148 year: 2018 end-page: 157 ident: bib33 article-title: Comparison of cancer diagnosis recording between the Clinical Practice Research Datalink, Cancer Registry and Hospital Episodes Statistics publication-title: Cancer Epidemiol – volume: 106 year: 2014 ident: bib11 article-title: Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009 publication-title: J Natl Cancer Inst – volume: 10 start-page: 337 year: 2010 ident: bib35 article-title: Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials publication-title: BMC Cancer – volume: 64 start-page: 562 year: 2007 end-page: 568 ident: bib18 article-title: Bias in occupational epidemiology studies publication-title: Occup Environ Med – volume: 18 start-page: 1018 year: 2018 ident: bib43 article-title: Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK Clinical Practice Research Datalink publication-title: BMC Cancer – volume: 7 start-page: 4952 year: 2018 end-page: 4963 ident: bib10 article-title: Incidence of cardiovascular disease up to 13 year after cancer diagnosis: a matched cohort study among 32 757 cancer survivors publication-title: Cancer Med – volume: 34 start-page: 1122 year: 2016 end-page: 1130 ident: bib19 article-title: Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study publication-title: J Clin Oncol – volume: 70 start-page: 2552 year: 2017 end-page: 2565 ident: bib5 article-title: Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2 publication-title: J Am Coll Cardiol – year: 2019 ident: bib21 article-title: The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study publication-title: J Natl Cancer Inst – volume: 45 start-page: 1887 year: 2017 end-page: 1894 ident: bib15 article-title: Robust causal inference using directed acyclic graphs: the R package ‘dagitty’ publication-title: Int J Epidemiol – volume: 104 start-page: 1293 year: 2012 end-page: 1305 ident: bib36 article-title: Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study publication-title: J Natl Cancer Inst – volume: 118 start-page: 1008 year: 2016 end-page: 1020 ident: bib38 article-title: Cardio-oncology: an update on cardiotoxicity of cancer-related treatment publication-title: Circ Res – volume: 32 start-page: 831 year: 2016 end-page: 841 ident: bib7 article-title: Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy publication-title: Can J Cardiol – volume: 94 start-page: 1061 year: 2016 end-page: 1072 ident: bib24 article-title: Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors publication-title: Int J Radiat Oncol Biol Phys – year: 2018 ident: bib14 article-title: Read codes – volume: 346 year: 2013 ident: bib32 article-title: Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study publication-title: BMJ – volume: 154 start-page: 1 year: 2018 end-page: 10 ident: bib27 article-title: Socio-economic inequalities in the incidence of four common cancers: a population-based registry study publication-title: Public Health – volume: 37 start-page: 2768 year: 2016 end-page: 2801 ident: bib2 article-title: 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology publication-title: Eur Heart J – volume: 70 start-page: 2536 year: 2017 end-page: 2551 ident: bib4 article-title: Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1 publication-title: J Am Coll Cardiol – volume: 9 start-page: 265 year: 2009 end-page: 290 ident: bib16 article-title: Further development of flexible parametric models for survival analysis publication-title: Stata J – volume: 133 start-page: 601 year: 2016 end-page: 609 ident: bib17 article-title: Introduction to the analysis of survival data in the presence of competing risks publication-title: Circulation – volume: 134 start-page: 1519 year: 2016 end-page: 1531 ident: bib9 article-title: Cardiac mortality among 200 000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the Teenage and Young Adult Cancer Survivor Study publication-title: Circulation – year: 2019 ident: bib25 article-title: Deprivation data – volume: 29 start-page: 2920 year: 2010 end-page: 2931 ident: bib34 article-title: Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values publication-title: Stat Med – volume: 36 start-page: 2135 year: 2018 end-page: 2144 ident: bib6 article-title: Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention publication-title: J Clin Oncol – volume: 137 start-page: e30 year: 2018 end-page: e66 ident: bib8 article-title: Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association publication-title: Circulation – volume: 34 start-page: 91 year: 2019 end-page: 99 ident: bib13 article-title: Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications publication-title: Eur J Epidemiol – volume: 123 start-page: 468 year: 2017 end-page: 475 ident: bib28 article-title: Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study publication-title: Cancer – volume: 20 start-page: 1721 year: 2018 end-page: 1731 ident: bib40 article-title: Activity and outcomes of a cardio-oncology service in the United Kingdom—a five-year experience publication-title: Eur J Hear Fail – volume: 146 start-page: 401 year: 2014 end-page: 409 ident: bib22 article-title: Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study publication-title: Breast Cancer Res Treat – year: 2019 ident: bib1 article-title: Cancer statistics for the UK – volume: 44 start-page: 827 year: 2015 end-page: 836 ident: bib12 article-title: Data resource profile: Clinical Practice Research Datalink (CPRD) publication-title: Int J Epidemiol – volume: 103 start-page: 947 year: 2010 end-page: 953 ident: bib29 article-title: Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006 publication-title: Br J Cancer – volume: 34 start-page: 1122 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib19 article-title: Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study publication-title: J Clin Oncol doi: 10.1200/JCO.2015.64.0409 – volume: 106 year: 2014 ident: 10.1016/S0140-6736(19)31674-5_bib11 article-title: Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943–2009 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju110 – volume: 133 start-page: 601 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib17 article-title: Introduction to the analysis of survival data in the presence of competing risks publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.017719 – volume: 118 start-page: 1008 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib38 article-title: Cardio-oncology: an update on cardiotoxicity of cancer-related treatment publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.303633 – volume: 29 start-page: 2920 year: 2010 ident: 10.1016/S0140-6736(19)31674-5_bib34 article-title: Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values publication-title: Stat Med doi: 10.1002/sim.3944 – volume: 70 start-page: 2536 year: 2017 ident: 10.1016/S0140-6736(19)31674-5_bib4 article-title: Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.09.1096 – volume: 34 start-page: 91 year: 2019 ident: 10.1016/S0140-6736(19)31674-5_bib13 article-title: Approach to record linkage of primary care data from Clinical Practice Research Datalink to other health-related patient data: overview and implications publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0442-4 – volume: 18 start-page: 1018 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib43 article-title: Statin use in cancer survivors versus the general population: cohort study using primary care data from the UK Clinical Practice Research Datalink publication-title: BMC Cancer doi: 10.1186/s12885-018-4947-8 – volume: 133 start-page: 1104 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib3 article-title: Shared risk factors in cardiovascular disease and cancer publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.115.020406 – year: 2019 ident: 10.1016/S0140-6736(19)31674-5_bib23 article-title: Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona publication-title: Clin Transl Oncol doi: 10.1007/s12094-018-02015-5 – volume: 37 start-page: 2768 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib2 article-title: 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology publication-title: Eur Heart J doi: 10.1093/eurheartj/ehw211 – volume: 154 start-page: 1 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib27 article-title: Socio-economic inequalities in the incidence of four common cancers: a population-based registry study publication-title: Public Health doi: 10.1016/j.puhe.2017.10.005 – volume: 40 start-page: 1756 year: 2019 ident: 10.1016/S0140-6736(19)31674-5_bib41 article-title: Cardio-oncology services: rationale, organization, and implementation publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy453 – volume: 137 start-page: e30 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib8 article-title: Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000000556 – volume: 70 start-page: 2552 year: 2017 ident: 10.1016/S0140-6736(19)31674-5_bib5 article-title: Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2 publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2017.09.1095 – volume: 45 start-page: 1887 year: 2017 ident: 10.1016/S0140-6736(19)31674-5_bib15 article-title: Robust causal inference using directed acyclic graphs: the R package ‘dagitty’ publication-title: Int J Epidemiol – volume: 32 start-page: 831 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib7 article-title: Canadian Cardiovascular Society guidelines for evaluation and management of cardiovascular complications of cancer therapy publication-title: Can J Cardiol – volume: 368 start-page: 987 year: 2013 ident: 10.1016/S0140-6736(19)31674-5_bib37 article-title: Risk of ischemic heart disease in women after radiotherapy for breast cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1209825 – volume: 103 start-page: 947 year: 2010 ident: 10.1016/S0140-6736(19)31674-5_bib29 article-title: Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605883 – volume: 346 year: 2013 ident: 10.1016/S0140-6736(19)31674-5_bib32 article-title: Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study publication-title: BMJ doi: 10.1136/bmj.f2350 – volume: 69 start-page: 4 year: 2010 ident: 10.1016/S0140-6736(19)31674-5_bib31 article-title: Validation and validity of diagnoses in the General Practice Research Database: a systematic review publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.2009.03537.x – volume: 36 start-page: 2135 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib6 article-title: Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention publication-title: J Clin Oncol doi: 10.1200/JCO.2017.76.3920 – volume: 146 start-page: 401 year: 2014 ident: 10.1016/S0140-6736(19)31674-5_bib22 article-title: Incident comorbidities and all-cause mortality among 5-year survivors of stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-014-3021-8 – volume: 134 start-page: 1519 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib9 article-title: Cardiac mortality among 200 000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the Teenage and Young Adult Cancer Survivor Study publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.116.022514 – volume: 94 start-page: 1061 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib24 article-title: Cardiovascular disease risk in a large, population-based cohort of breast cancer survivors publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2015.11.040 – volume: 23 start-page: 604 year: 2012 ident: 10.1016/S0140-6736(19)31674-5_bib26 article-title: Death causes in breast cancer patients publication-title: Ann Oncol doi: 10.1093/annonc/mdr160 – volume: 44 start-page: 827 year: 2015 ident: 10.1016/S0140-6736(19)31674-5_bib12 article-title: Data resource profile: Clinical Practice Research Datalink (CPRD) publication-title: Int J Epidemiol doi: 10.1093/ije/dyv098 – volume: 2 start-page: 27 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib20 article-title: Comparison of guidelines on non-muscle invasive bladder cancer (EAU, CUA, AUA, NCCN, NICE) publication-title: Bl Cancer – volume: 64 start-page: 562 year: 2007 ident: 10.1016/S0140-6736(19)31674-5_bib18 article-title: Bias in occupational epidemiology studies publication-title: Occup Environ Med doi: 10.1136/oem.2006.026690 – volume: 104 start-page: 1293 year: 2012 ident: 10.1016/S0140-6736(19)31674-5_bib36 article-title: Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djs317 – volume: 357 year: 2017 ident: 10.1016/S0140-6736(19)31674-5_bib39 article-title: Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study publication-title: BMJ – volume: 57 start-page: 148 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib33 article-title: Comparison of cancer diagnosis recording between the Clinical Practice Research Datalink, Cancer Registry and Hospital Episodes Statistics publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2018.08.009 – volume: 20 start-page: 1721 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib40 article-title: Activity and outcomes of a cardio-oncology service in the United Kingdom—a five-year experience publication-title: Eur J Hear Fail doi: 10.1002/ejhf.1292 – volume: 127 start-page: 849 year: 2016 ident: 10.1016/S0140-6736(19)31674-5_bib30 article-title: When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data publication-title: Blood doi: 10.1182/blood-2015-01-625582 – volume: 123 start-page: 468 year: 2017 ident: 10.1016/S0140-6736(19)31674-5_bib28 article-title: Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: a population-based cohort study publication-title: Cancer doi: 10.1002/cncr.30364 – volume: 7 start-page: 4952 year: 2018 ident: 10.1016/S0140-6736(19)31674-5_bib10 article-title: Incidence of cardiovascular disease up to 13 year after cancer diagnosis: a matched cohort study among 32 757 cancer survivors publication-title: Cancer Med doi: 10.1002/cam4.1754 – volume: 10 start-page: 337 year: 2010 ident: 10.1016/S0140-6736(19)31674-5_bib35 article-title: Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials publication-title: BMC Cancer doi: 10.1186/1471-2407-10-337 – volume: 65 start-page: e761 year: 2015 ident: 10.1016/S0140-6736(19)31674-5_bib42 article-title: Caring for people living with, and beyond, cancer: an online survey of GPs in England publication-title: Br J Gen Pract doi: 10.3399/bjgp15X687409 – year: 2019 ident: 10.1016/S0140-6736(19)31674-5_bib21 article-title: The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djy218 – volume: 9 start-page: 265 year: 2009 ident: 10.1016/S0140-6736(19)31674-5_bib16 article-title: Further development of flexible parametric models for survival analysis publication-title: Stata J doi: 10.1177/1536867X0900900206 – reference: 32563368 - Lancet. 2020 Jun 20;395(10241):1903-1904 – reference: 31443925 - Lancet. 2019 Sep 21;394(10203):986-988 – reference: 32563370 - Lancet. 2020 Jun 20;395(10241):1904 |
| SSID | ssj0004605 |
| Score | 2.694288 |
| Snippet | The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk in survivors.... Summary Background The past few decades have seen substantial improvements in cancer survival, but concerns exist about long-term cardiovascular disease risk... |
| SourceID | swepub pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1041 |
| SubjectTerms | Adolescent Adult Aged Aged, 80 and over Arrhythmia Bladder Blood cancer Cancer Survivors - statistics & numerical data Cancer therapies Cardiomyopathy Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Case-Control Studies Chemotherapy Cohort analysis Cohort Studies Congestive heart failure Coronary artery Coronary artery disease Coronary vessels Diagnosis Electronic health records Electronic medical records Esophagus Female Health care Health risk assessment Health risks Heart diseases Heart failure Hematology Humans Incidence Leukemia Lymphoma Male Medical diagnosis Melanoma Middle Aged Multiple myeloma Neoplasms - epidemiology Non-Hodgkin's lymphoma Pancreatic cancer Patients Pericarditis Population Population studies Population-based studies Primary care Proportional Hazards Models Prostate Prostate cancer Registries Risk Risk Assessment Risk factors Stroke Survival Thromboembolism United Kingdom - epidemiology Young Adult Young adults |
| Title | Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673619316745 https://dx.doi.org/10.1016/S0140-6736(19)31674-5 https://www.ncbi.nlm.nih.gov/pubmed/31443926 https://www.proquest.com/docview/2293784071 https://www.proquest.com/docview/2296129529 https://pubmed.ncbi.nlm.nih.gov/PMC6857444 http://kipublications.ki.se/Default.aspx?queryparsed=id:141910350 |
| Volume | 394 |
| WOSCitedRecordID | wos000487038700031&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Database Suite (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYhhAvfH8URnVICMFDmJMmtsMLgmkTEmqpxob6FqV2MipGUpJ2_x3_G3eOkyraYEi8nNLEVzXp5e5n-3d3jL2YU5hCu_Vyg69baAT35mmgvTxXcz5S2hdG22YTcjJRs1k8dQtutaNVtj7ROmpTaloj3wswLklF0493y58edY2i3VXXQmOL7VCVhJGl7k0vy4u0FPdNBs_el-7kKz9-TengoRf9KTZdxJ4XKZS9QqM2OB3e_t_busNuOVgK7xs7usuuZcU9dmPsNt7vs190uP4BaWHgrCxOPfLoQLz0GsocKF-TOEege_RWcNs_NSwKqNfolc7LyioEHGzlD1RAq6vqt5DCsusl5lFsNUDNe6sV2Aq4QAT9U2j5j0Abzzjk5BNsGvlAk9QJzcJTDcR-pW-qH7CTw4Pj_Y-e6_zgaRGNVl4Ya0SmCE39OT5iHqW5kTLDmZZMfV9rpUw-Mqk0JufcRDzMUj6PUy50xrUkGPKQbRdlkT1mgBhEZzFGpFyIUEa5io0wyudxisaRBeGAhe1_nmhXFp26c5wll_Df_DixppJEA_amU1s2dUGuUhCtQSVt0iu66QQj11WKqlN0qKhBO_-iutsaXeJcU51sLG7AnneX0anQTlFaZOXajkHkG0dBPGCPGkPv7nKEU3AE1WLAZO8V6AZQwfL-lWLxzRYuFyqSYYiP_GXzsvRU3KnveJQlIc5KpHjy99__lN1E-GoZf4G_y7ZX1Tp7xq7r89WiroZsSx59JTmTViqUat8fsp0PB5PpEX4a80YekwzGVn62cjq0juQ32bhw1A |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqgoAL70egwCABgkOok3XsBAkhBFSttrtCYiv1FrK2U1aUZNnsFvGn-Af8N2acx2rVQrn0wC1KPFHizONz_M0MY4_HFKZQb_3coLkJI7k_zkLt53k85r1YB9Jo12xCDYfx_n7yYY39bHNhiFbZ-kTnqE2p6R_5ZohxScW0_Hg9_eZT1yjaXW1baNRq0bc_vuOSrXq18w6_75Mw3Ho_ervtN10FfC2j3twXiUbUg7AnGFujeZTlRimLKF5lQaB1HJu8ZzJlTM65ibiwGR8nGZfacq24K3SALv8c1dUjCuGAj07Kw3SU-mXG0ObH7uSzIHlO6efCj_4UC49j3eOUzZXCpi4Ybl3536bxKrvcwG54U9vJNbZmi-vswqAhFtxgv-hw8RWywsBhWRz4FLGAePcVlDlQPipxqkCv0Heh2d6qYFJAtUCve1TOnEDIwVU2QQG0qln1EjKYdr3SfMIOBqg58WwOrsIvUALCAbT8TqCNdRyy14dloyKok1ah_rFWAbF76U7VTbZ3JpN3i60XZWHvMECMpW2CETeXUqgojxMjTRzwJENltKHwmGh1LNVN2XfqPnKYnsDvC5LUqWYaeexFJzat656cJiBbBU7bpF4MQylG5tME406wQX01mvsX0Y1WydPG9VbpUsM99qi7jE6TdsKywpYLNwaRfRKFicdu14bVvWUvEAjSQ-kxtWJy3QAqyL56pZh8doXZZRwpIXDKn9bGuSLSnPqCRzYVuOpS8u7fn_8hu7g9GuymuzvD_j12CaG6YzeGwQZbn88W9j47r4_mk2r2wLkhYJ_O2mB_A8aXxRc |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaqgiouvB8LBQYJEBzCOlnHTpAQQi0rqoVVJajUW5rYTllRkmWzW8RfQ-K_MeM8VqsWyqUHblHiiRJnHp_jb2YYe5xRmEK99XKD5iaM5F6WBtrL8yjjg0j70mjXbEKNx9H-fry7xn62uTBEq2x9onPUptT0j7wfYFxSES0_-nlDi9jdHr6efvOogxTttLbtNGoVGdkf33H5Vr3a2cZv_SQIhm8_bb3zmg4DnpbhYO6JWCMCQgjkZ9ZoHqa5Ucoiolep72sdRSYfmFQZk3NuQi5syrM45VJbrhV3RQ_Q_V9QA9RiylLf8k_LyXT0-mX2UP9jd_KZHz-nVHThhX-Kiydx70n65kqRUxcYh1f-5ym9yi43cBze1PZzja3Z4jrb-NAQDm6wX3S4-AppYeCoLA49imRAfPwKyhwoT5W4VqBXaL3QbHtVMCmgWqA3Pi5nTiDg4CqeoABa26x6CSlMux5qHmEKA9S0eDYHV_kXKDHhEFreJ9CGOw7ZG8GygRHUyaxQ_3CrgFi_dKfqJts7l8m7xdaLsrB3GCD20jbGSJxLKVSYR7GRJvJ5nKJi2kD0mGj1LdFNOXjqSnKUnML78-PEqWkS9tiLTmxa10M5S0C2ypy0yb4YnhKM2GcJRp1ggwZrlPcvoputwieNS66Spbb32KPuMjpT2iFLC1su3BhE_HEYxD12uzay7i0HvkDwHsgeUyvm1w2gQu2rV4rJZ1ewXUahEgKn_GltqCsizakveGQTgasxJe_-_fkfsg200-T9znh0j11CBO9Ij4G_ydbns4W9zy7q4_mkmj1wHgnYwXnb62-yOM2V |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medium+and+long-term+risks+of+specific+cardiovascular+diseases+in+survivors+of+20+adult+cancers%3A+a+population-based+cohort+study+using+multiple+linked+UK+electronic+health+records+databases&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Strongman%2C+Helen&rft.au=Gadd%2C+Sarah&rft.au=Matthews%2C+Anthony&rft.au=Mansfield%2C+Kathryn+E&rft.date=2019-09-21&rft.pub=Elsevier+Ltd&rft.issn=0140-6736&rft.volume=394&rft.issue=10203&rft.spage=1041&rft.epage=1054&rft_id=info:doi/10.1016%2FS0140-6736%2819%2931674-5&rft.externalDocID=S0140673619316745 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-6736&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-6736&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-6736&client=summon |